Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 10Terminated 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Lymphoma, Follicular 1Crohn Disease 1Colitis, Ulcerative 1Breast Neoplasms 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 144Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Vitamin E × Clear all
NCT03916068 2023-10-04

Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation Therapy

Legacy Health System

Phase 2 Terminated
1 enrolled
Breast

Breast Neoplasms

NCT00152841 2009-03-17

Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis

University Health Network, Toronto

Phase 2 Terminated
30 enrolled
Lymphoid

Colitis, Ulcerative, Crohn Disease, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡